Highly Accurate Blood Test Identifies Patients Whose Prostate Cancer Is More Likely to Spread

Highly Accurate Blood Test Identifies Patients Whose Prostate Cancer Is More Likely to Spread
Researchers at Queen Mary University of London have discovered that the blood levels of circulating tumor cells and megakaryocytes (platelet-producing cells) may help identify patients with aggressive metastatic prostate cancer, allowing them to receive targeted treatments sooner. The study, “The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis,” was published in the journal Clinical Cancer Research, and

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

Leave a Comment

Your email address will not be published. Required fields are marked *